207 related articles for article (PubMed ID: 22671573)
21. Assessment of microvascular density, extracellular volume fraction, and radiobiological hypoxia in human melanoma xenografts by dynamic contrast-enhanced MRI.
Vestvik IK; Egeland TA; Gaustad JV; Mathiesen B; Rofstad EK
J Magn Reson Imaging; 2007 Oct; 26(4):1033-42. PubMed ID: 17896373
[TBL] [Abstract][Full Text] [Related]
22. Fluctuations in tumor blood perfusion assessed by dynamic contrast-enhanced MRI.
Brurberg KG; Benjaminsen IC; Dørum LM; Rofstad EK
Magn Reson Med; 2007 Sep; 58(3):473-81. PubMed ID: 17763357
[TBL] [Abstract][Full Text] [Related]
23. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts.
Benjaminsen IC; Graff BA; Brurberg KG; Rofstad EK
Magn Reson Med; 2004 Aug; 52(2):269-76. PubMed ID: 15282808
[TBL] [Abstract][Full Text] [Related]
24. Assessment of tumor hypoxia and interstitial fluid pressure by gadomelitol-based dynamic contrast-enhanced magnetic resonance imaging.
Gulliksrud K; Hompland T; Galappathi K; Rofstad EK
Radiother Oncol; 2011 Oct; 101(1):217-22. PubMed ID: 21840612
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.
Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
Radiother Oncol; 2013 Apr; 107(1):117-22. PubMed ID: 23333024
[TBL] [Abstract][Full Text] [Related]
26. Quantitative dynamic contrast-enhanced MRI for the assessment of mandibular invasion by squamous cell carcinoma.
Van Cann EM; Rijpkema M; Heerschap A; van der Bilt A; Koole R; Stoelinga PJ
Oral Oncol; 2008 Dec; 44(12):1147-54. PubMed ID: 18485797
[TBL] [Abstract][Full Text] [Related]
27. Changes in intratumor heterogeneity in blood perfusion in intradermal human melanoma xenografts during tumor growth assessed by DCE-MRI.
Graff BA; Benjaminsen IC; Melås EA; Brurberg KG; Rofstad EK
Magn Reson Imaging; 2005 Nov; 23(9):961-6. PubMed ID: 16310112
[TBL] [Abstract][Full Text] [Related]
28. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
[TBL] [Abstract][Full Text] [Related]
29. Segmentation of dynamic contrast enhanced magnetic resonance imaging data.
Nielsen T; Mouridsen K; Maxwell RJ; Stødkilde-Jørgensen H; Østergaard L; Horsman MR
Acta Oncol; 2008; 47(7):1265-70. PubMed ID: 18661437
[TBL] [Abstract][Full Text] [Related]
30. Connective tissue of cervical carcinoma xenografts: associations with tumor hypoxia and interstitial fluid pressure and its assessment by DCE-MRI and DW-MRI.
Hompland T; Ellingsen C; Galappathi K; Rofstad EK
Acta Oncol; 2014 Jan; 53(1):6-15. PubMed ID: 23445339
[TBL] [Abstract][Full Text] [Related]
31. Interstitial fluid pressure and vascularity of intradermal and intramuscular human tumor xenografts.
Gulliksrud K; Galappathi K; Rofstad EK
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):258-64. PubMed ID: 21255944
[TBL] [Abstract][Full Text] [Related]
32. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
Hsu YH; Ferl GZ; Ng CM
Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680
[TBL] [Abstract][Full Text] [Related]
33. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
Cheng HL; Wallis C; Shou Z; Farhat WA
J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
[TBL] [Abstract][Full Text] [Related]
34. DCE-MRI of patient-derived xenograft models of uterine cervix carcinoma: associations with parameters of the tumor microenvironment.
Hauge A; Wegner CS; Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK
J Transl Med; 2017 Nov; 15(1):225. PubMed ID: 29100521
[TBL] [Abstract][Full Text] [Related]
35. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
[TBL] [Abstract][Full Text] [Related]
36. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
[TBL] [Abstract][Full Text] [Related]
37. Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil.
van Laarhoven HW; Klomp DW; Rijpkema M; Kamm YL; Wagener DJ; Barentsz JO; Punt CJ; Heerschap A
NMR Biomed; 2007 Apr; 20(2):128-40. PubMed ID: 17006886
[TBL] [Abstract][Full Text] [Related]
38. Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI.
Egeland TA; Gaustad JV; Vestvik IK; Benjaminsen IC; Mathiesen B; Rofstad EK
Magn Reson Med; 2006 Apr; 55(4):874-82. PubMed ID: 16506163
[TBL] [Abstract][Full Text] [Related]
39. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
[TBL] [Abstract][Full Text] [Related]
40. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
